mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.6 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.6 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |